Peter George has over 30 years’ experience in Senior and Board level management including 12 years as CEO and 5 as a non-executive director.
Qualified in Pathology, Peter has a background in pharmaceuticals, pharma services, CRO, healthcare and life sciences, publishing and business intelligence.
In 2010, Peter was awarded European Private Equity CEO of the Year and in 2016, stepped down as CEO of Clinigen Group plc, a global specialty pharmaceuticals and pharmaceutical services business with a c.£1bn market cap, and one of the most successful recent floats on AIM. Prior to Clinigen, he was CEO at Penn Pharma, having led a £67m management buy-out in 2007 and Executive Vice President for Wolters Kluwer Health with responsibility for Europe and Asia Paciﬁc regions.
Peter took up the chairmanship of Rentplus in 2018 and held the post until December 2019. He is also President of Enigma Holdings Group Limited and of companies including Ergomed plc, Benchmark Holdings plc. He is Chairman/Director of several companies he owns or has significant holdings in, including Mitre Group Ltd, XPG Holdings Ltd, Marco Polo Events Ltd (UK Challenge), and Eminent Sports Group (ESG Ltd).